| FB01030 |
Zanamivir
|
139110-80-8 |
Zanamivir is the first of two registered neuraminidase inhibitors for the treatment and prophylaxis of influenza. Zanamivir could inhibit SARS-CoV-2 3CLpro main protease. |
| FB04144 |
Peramivir Trihydrate
|
1041434-82-5 |
Peramivir Trihydrate is a novel cyclopentane neuraminidase inhibitor of influenza virus, used to treat acute symptomatic influenza A and B. |
| FB07904 |
Oseltamivir Phosphate
|
204255-11-8 |
Oseltamivir Phosphate is a neuraminidase inhibitor used to treat and prevent influenza A and influenza B. |
| FB16817 |
3CLpro inhibitor 3g
|
1945974-05-9 |
3CLpro inhibitor 3g could inhibit H5N1 neuraminidase with IC50 of 2.9μM, as well as inhibited SARS 3CLpro and MERS 3CLpro with IC50 values of 20.2 ± 0.3μM and 10.1 ± 1.8μM, respectively. |
| FB16818 |
3CLpro inhibitor 3f
|
1945974-03-7 |
3CLpro inhibitor 3f could inhibit H5N1 neuraminidase with IC50 of 2.8μM, as well as inhibited SARS 3CLpro and MERS 3CLpro with IC50 values of 16.4 ± 0.7μM and 12.2 ± 2.2μM, respectively. |